Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 July 2020 | Story Nitha Ramnath | Photo istock

Date: 28 July 2020
Time: 14:00 – 15:30

Gender inequalities domestic violence and gender-based violence (GBV) are global concerns, and have been exacerbated by the impact of Covid-19 as women take on more child and care work responsibilities.  Jobs lost in service sectors often affect women most, large numbers of frontline health workers and teachers are women, and lockdowns increase domestic violence. Thus President Cyril Ramaphosa recently said in a televised address that more than 21 women and children have been murdered in South Africa within just a few weeks in what he referred to as “another pandemic raging in our country.” He said this “violence being unleashed on women and children with a brutality that defies comprehension, is no less than a war being waged against the women and children of our country”.

As the World Economic Forum points out, regardless of where one looks, it is women who bear most of the responsibility for holding societies together, be it at home, in health care, at school, or in caring for the elderly. In many countries, women perform these tasks without pay. 

Now, the Covid-19 pandemic is compounding existing gender inequalities, and increasing risks of gender-based violence. Gender inequality, layered along with the effects of the pandemic, lockdowns and the economic downturn, could leave a deep and lasting impact on the lives and opportunities of women and girls.

Given, then, that the COVID-19 crisis affects women and girls in different ways from men and boys, measures to resolve it must take gender into account, and the protection and promotion of the rights of women and girls prioritized. 
To take up these issues of gender inequalities and gender-based violence, two renowned gender research experts will take part in our webinar. The webinar will be chaired by Professor Melanie Walker of the University of the Free State.  The presenters are: Professor Pumla Gqola, Professor of Women and Gender Studies at Nelson Mandela University and author of Rape: A South African Nightmare. Lisa Vetten has worked in the field of violence against women for over two decades as a counsellor, para-legal, trainer and researcher. She is currently an honorary research associate at the Wits Institute for Social and Economic Research (WiSER).

Join us from 14:00 to 15:30 on 28 July. 

RSVP to Sibongile Mlotya at MlotyaS@ufs.ac.za no later than 26 July, upon which you will receive a Business for Skype meeting invite.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept